From: Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Cell origin | Disease | Up-regulated cargos | Down-regulate cargos | Outcome of EV cargo alteration | References |
---|---|---|---|---|---|
Neuron | AD | P-T181-tau, Aβ1−42, cathepsin D | – | Promoting Aβ deposition and NFT formation | [84] |
 | AD | APP mRNA & protein | – | Facilitating the production of Aβ | [10] |
 | AD | miR-124, miR-155, miR-146a, miR-21, miR-125b | – | Inducing microglial activation and pro-inflammatory cytokine release | [87] |
 | AD | – | miR-185 | Elevating APP expression levels | [10] |
 | PD | α-syn | – | Inducing neurotoxicity and α-syn-rich Lewy bodies formation | [272] |
 | PD | Rab8b, Rab31 | – | Contributing to non-motor symptoms in PD pathology including hearing loss | [123] |
 | PD | 20 S Proteasome complex, PARK7, Gelsolin, Amyloid P component, Clusterin | – | Participating in PD onset and progression | [124] |
 | PD | miR-19a-3p, miR-155 | – | Mediating α-syn-induced inflammatory responses | [121] |
 | ALS | mutant SOD1 | – | Inducing mitochondrial toxicity | [138] |
 | ALS | DPRs, TDP-43 | – | Inducing astrocyte toxicity and neurodegeneration | [139] |
 | ALS | miR-4736, miR-4700-5p, miR-1207-5p, miR-4739, miR-4505, miR-24-3p, miR-149-3p, etc. | miR-1268a, miR-2861, miR-4508, miR-4507, miR-3176, miR-3911, miR-150-3p, etc. | Disturbing neuroplasticity and enhancing neural damage | [141] |
 | HD | mutant HTT | – | Inducing neurodegeneration | [156] |
Astrocyte | AD | p-Tau | – | Enhancing the formation of NFT | [95] |
 | AD | BACE1, complement proteins | – | Promoting Aβ cleavage and neuronal damage | |
 | PD | – | miR-200a-3p | Inhibiting c-Jun N-terminal kinase cell death pathway | [129] |
 | ALS | mutant SOD1 | – | Inducing selective motor neuron death | [146] |
 | ALS | – | miR-494-3p | Unlocking SEMA3A-induced motor neuron degeneration | [147] |
 | ALS | IL-6 | – | Exacerbating pro-inflammatory responses of neuroglial cells | [148] |
 | HD | – | CRYAB | Suppressing EV secretion | [273] |
Microglia | AD | Human tau | – | Spreading of tau protein | [80] |
 | AD | TREM2 | – | Changing environment around Aβ and promoting microglia to phagocytose Aβ | [114] |
 | AD | APP/Aβ, P2RY12, TMEM119, FTH1, TREM2 | – | Stimulating microglial activation and contributing to Aβ deposition | |
 | AD | Cholesterol, BMP, MhCer lipid species | DHA-containing polyunsaturated lipids | Inducing defect in acyl-chain remodeling | [112] |
 | AD | miR-28-5p, miR-381-3p, miR-651-5p, miR-188-5p | – | Enhancing neuroinflammation and cellular senescence | [112] |
 | PD | α-syn | – | Spreading α-syn oligomers through microglia-neuron α-syn transmission | [130] |
 | PD | MHC class II molecules, TNF-α | – | Triggering neuroinflammation and dopaminergic neurodegeneration | |
 | ALS | mutant SOD1 | – | Inducing neurotoxicity and motor neuron death | [150] |
 | ALS | HMGB1, miR-155, miR-146a | – | Activating microglia and impairing mitophagy | [151] |
Oligodendrocyte | PD | α-syn | – | Inducing neurotoxicity and formation of α-syn-rich Lewy bodies | [136] |